Hong Kong's Hospital Authority pledges to reduce ethics review process on clinical trials from 6 months to 30 days starting next year

New arrangement expected to come into effect in first quarter of 2024, according to authority director Michael Wong.

Related Keywords

University Of Hong Kong ,Hong Kong General ,Hong Kong ,Australia ,China ,Singapore ,John Lee Ka Chiu , ,Our Hong Kong Foundation ,A Cluster Clinical Research Support Office ,Hong Kong Association Of The Pharmaceutical Industry ,Chief Executive John Lee Ka Chiu ,Cluster Clinical Research Support Office ,Ivan Hung Fan Ngai ,Hong Kong Foundation ,Chan So Kuen ,Hong Kong Association ,Pharmaceutical Industry ,